Please find enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) REgulations, 2011 in connection with intimation of pledge.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.3 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudarshan Pharma Industries Ltd has informed BSE about the release of a pledge on its shares, filed under Regulation 31(2) of SEBI's Takeover Regulations, 2011. The disclosure was submitted on 5th June 2026 by Sachin Mehta, Joint Managing Director. The specific details of the number of shares, pledge value, and the entity involved in the pledge release are not clearly readable in the submitted document. The filing is a routine regulatory disclosure required when promoters or substantial shareholders release pledged shares.
A release of pledge is generally seen as a positive signal for shareholders, as it indicates reduced leverage risk and improved financial flexibility for the promoter. It may ease concerns about potential forced selling of shares.